Biose Industrie is a French CDMO specialized in microbiome therapeutics, established in 1951. They focus on manufacturing Live Biotherapeutic Products (LBPs) and Next-Generation Probiotics (NGPs) for pharmaceutical and consumer health markets. They combine aerobic and anaerobic microbiology expertise with industrial-scale GMP manufacturing. Investing EUR 80 million to expand capacity from 8,000L to 32,000L fermentation volume at their Aurillac site. They offer full CDMO services from process development to GMP drug product manufacturing.
live biotherapeutic products (LBPs), next-generation probiotics (NGPs), aerobic/anaerobic fermentation, microbiome CDMO, GMP microbial manufacturing, lyophilization
2 sites worldwide
No reviews available yet.
No documents available.